Key Findings:  Results demonstrated that CBD was able to produce therapeutic effects relevant to a number of neuro-psychiatric conditions such as substance abuse and dependence, schizophrenia, social phobia, post-traumatic stress, depression, bipolar disorder, sleep disorders, epilepsy, and Parkinson disease.
Type of Study:  Meta-analysis
Study Result:  Positive
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Not Applicable
Chemotype:  Chemotype III